LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer
1. LIXTE relocates headquarters to Boca Raton to enhance operations. 2. New board members and CFO bring extensive experience to LIXTE. 3. LB-100 is aiding in cancer therapy with ongoing clinical trials. 4. Leadership changes aim to strengthen LIXTE's market position and business strategy. 5. Company emphasizes business-friendly environment to reduce costs for long-term value.